Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
Last trade$123.49
Day change-$1.12 (-0.90%)
Day range$122.45 – $124.87
Volume51,625
Market cap$2.32B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$2.32B
Price / earnings
20.91×
Price / book
1.97×
Price / sales
1.55×
EV / sales
1.5×
EV / EBITDA
13.09×
Profitability
Earnings per share
$5.96
Return on assets
7.66%
Return on equity
9.41%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.02×
Current ratio
1.64×
Quick ratio
1.64×
Cash ratio
0.57×
Cash flow
Price / cash flow
15.27×
Price / free cash flow
16.1×
Free cash flow
$144.23M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for ADUS, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$387.73M
$377.42M
$363.61M
$373.08M
$362.3M
$349.44M
$337.71M
$297.14M
Cost of revenue
$263.34M
$255.86M
$247.74M
$249.47M
$245.59M
$235.57M
$230.03M
$195.66M
Gross profit
$124.4M
$121.56M
$115.87M
$123.61M
$116.72M
$113.88M
$107.68M
$101.48M
Selling, general and administrative
$80.44M
$78.49M
$77.77M
$77.18M
$79.37M
$77.08M
$73.22M
$71.36M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$84.58M
$82.62M
$81.8M
$81.33M
$83.78M
$80.99M
$77.16M
$74.57M
Operating income
$39.82M
$38.94M
$34.07M
$42.28M
$32.94M
$32.89M
$30.51M
$26.91M
Interest expense
-$1.26M
-$1.72M
-$2.15M
-$2.73M
-$3.34M
-$3.53M
-$4.02M
-$2.29M
Income before taxes
$39.14M
$37.78M
$32.43M
$40.15M
$30.35M
$29.95M
$27M
$26.21M
Income taxes
$10.55M
$10.18M
$7.36M
$10.37M
$7.51M
$7.89M
$5.77M
$6.69M
Net income
$28.59M
$27.61M
$25.07M
$29.78M
$22.85M
$22.05M
$21.23M
$19.53M
Net income attributable to common shareholders
$28.59M
$27.61M
$25.07M
$29.78M
$22.85M
$22.05M
$21.23M
$19.53M
EBITDA
$43.96M
$43.07M
$38.1M
$46.43M
$37.35M
$36.8M
$34.46M
$30.13M
Basic earnings per share
$1.56
$1.51
$1.38
$1.64
$1.26
$1.22
$1.18
$1.09
Diluted earnings per share
$1.54
$1.49
$1.36
$1.61
$1.24
$1.20
$1.16
$1.06
Recent news
Company coverage with links to the original publishers.
Addus HomeCare (ADUS) demonstrates positive momentum with a Zacks Momentum Style Score of B and a #2 (Buy) rating. The stock has outperformed its industry over multiple timeframes, with shares up 3.06% weekly and 10.98% monthly, while earnings estimates have been revised upward over the past two months.
Addus HomeCare reported Q3 2026 revenue of $387.73 million, up 7% year-over-year, slightly missing the consensus estimate of $388.36 million. EPS came in at $1.83, beating the consensus estimate of $1.78 by 2.81%. Personal care revenue grew 9.2% while home health and hospice segments showed minimal growth. The stock has a Zacks Rank #3 (Hold) rating.
Addus HomeCare reported Q3 2026 earnings of $1.83 per share, beating consensus estimates of $1.78, but revenues of $387.73 million slightly missed expectations. The company has outperformed the market by 17.1% year-to-date. With a Zacks Rank #3 (Hold) rating and mixed estimate revisions, the stock is expected to perform in line with the market. The Medical - Outpatient and Home Healthcare industry ranks in the top 39% of Zacks industries.
Quest Diagnostics reported Q3 2026 earnings of $3.00 per share, beating consensus estimates of $2.85 and surpassing revenue expectations at $3.1 billion. The company has beaten EPS estimates in four consecutive quarters. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market. The Medical - Outpatient and Home Healthcare industry ranks in the top 31% of Zacks industries.
BrightSpring Health Services is leveraging AI and automation across hiring, intake, documentation, and patient care to improve productivity. The company reported 44% year-over-year adjusted EBITDA growth with margin expansion to 5.3%, with further benefits expected in late 2026 and early 2027. Peers Option Care Health and Addus HomeCare are similarly implementing AI-driven initiatives to enhance efficiency and reduce operational complexity.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.